Selected research
Industry Growth & Trends
Global Prostaglandin E2 Receptor EP4 Subtype Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Prostaglandin E2 Receptor EP4 Subtype market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Prostaglandin E2 Receptor EP4 Subtype is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Prostaglandin E2 Receptor EP4 Subtype is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Prostaglandin E2 Receptor EP4 Subtype is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Prostaglandin E2 Receptor EP4 Subtype market include Eisai Co Ltd, Eli Lilly and Co, Rottapharm Biotech Srl, RaQualia Pharma Inc, Ono Pharmaceutical Co Ltd and Kaken Pharmaceutical Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Prostaglandin E2 Receptor EP4 Subtype market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Prostaglandin E2 Receptor EP4 Subtype market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prostaglandin E2 Receptor EP4 Subtype market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prostaglandin E2 Receptor EP4 Subtype.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Prostaglandin E2 Receptor EP4 Subtype market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Prostaglandin E2 Receptor EP4 Subtype Market by Company
Eisai Co Ltd
Eli Lilly and Co
Rottapharm Biotech Srl
RaQualia Pharma Inc
Ono Pharmaceutical Co Ltd
Kaken Pharmaceutical Co Ltd
Prostaglandin E2 Receptor EP4 Subtype Segment by Type
ONO-4232
KAG-308
ER-886046
Grapiprant
E-7046
Others
Prostaglandin E2 Receptor EP4 Subtype Segment by Application
Breast Cancer
Chronic Pain
Acute Pain
Allergies
Lung Cancer
Others
Prostaglandin E2 Receptor EP4 Subtype Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin E2 Receptor EP4 Subtype market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin E2 Receptor EP4 Subtype and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin E2 Receptor EP4 Subtype.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Prostaglandin E2 Receptor EP4 Subtype companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- ONO-4232
- KAG-308
- ER-886046
- Grapiprant
- E-7046
- Others
Applications
- Breast Cancer
- Chronic Pain
- Acute Pain
- Allergies
- Lung Cancer
- Others
Companies covered
- Eisai Co Ltd
- Eli Lilly and Co
- Rottapharm Biotech Srl
- RaQualia Pharma Inc
- Ono Pharmaceutical Co Ltd
- Kaken Pharmaceutical Co Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2021-2032)
- 1.4.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2021-2026)
- 1.4.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2027-2032)
- 1.5 Key Regions Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032)
- 1.5.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (2021-2032)
- 1.5.4 South America Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (2021-2032)
2 Prostaglandin E2 Receptor EP4 Subtype Market by Type
- 2.1 Type Introduction
- 2.1.1 ONO-4232
- 2.1.2 KAG-308
- 2.1.3 ER-886046
- 2.1.4 Grapiprant
- 2.1.5 E-7046
- 2.1.6 Others
- 2.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
- 2.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Overview by Type (2021-2032)
- 2.2.2 Global Prostaglandin E2 Receptor EP4 Subtype Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Forecasted by Type (2027-2032)
- 2.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Regions
- 2.3.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Prostaglandin E2 Receptor EP4 Subtype Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Market Size Breakdown by Type (2021-2026)
3 Prostaglandin E2 Receptor EP4 Subtype Market by Application
- 3.1 Type Introduction
- 3.1.1 Breast Cancer
- 3.1.2 Chronic Pain
- 3.1.3 Acute Pain
- 3.1.4 Allergies
- 3.1.5 Lung Cancer
- 3.1.6 Others
- 3.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
- 3.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Overview by Application (2021-2032)
- 3.2.2 Global Prostaglandin E2 Receptor EP4 Subtype Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Forecasted by Application (2027-2032)
- 3.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Regions
- 3.3.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Prostaglandin E2 Receptor EP4 Subtype Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Prostaglandin E2 Receptor EP4 Subtype Industry Trends
- 4.2 Prostaglandin E2 Receptor EP4 Subtype Industry Drivers
- 4.3 Prostaglandin E2 Receptor EP4 Subtype Industry Opportunities and Challenges
- 4.4 Prostaglandin E2 Receptor EP4 Subtype Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Prostaglandin E2 Receptor EP4 Subtype Revenue (2021-2026)
- 5.2 Global Prostaglandin E2 Receptor EP4 Subtype Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Prostaglandin E2 Receptor EP4 Subtype Key Company Headquarters & Area Served
- 5.4 Global Prostaglandin E2 Receptor EP4 Subtype Company, Product Type & Application
- 5.5 Global Prostaglandin E2 Receptor EP4 Subtype Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Prostaglandin E2 Receptor EP4 Subtype Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Prostaglandin E2 Receptor EP4 Subtype Players Market Share by Revenue in 2025
- 5.6.3 2025 Prostaglandin E2 Receptor EP4 Subtype Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Eisai Co Ltd
- 6.1.1 Eisai Co Ltd Company Information
- 6.1.2 Eisai Co Ltd Business Overview
- 6.1.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
- 6.1.5 Eisai Co Ltd Recent Developments
- 6.2 Eli Lilly and Co
- 6.2.1 Eli Lilly and Co Company Information
- 6.2.2 Eli Lilly and Co Business Overview
- 6.2.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
- 6.2.5 Eli Lilly and Co Recent Developments
- 6.3 Rottapharm Biotech Srl
- 6.3.1 Rottapharm Biotech Srl Company Information
- 6.3.2 Rottapharm Biotech Srl Business Overview
- 6.3.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
- 6.3.5 Rottapharm Biotech Srl Recent Developments
- 6.4 RaQualia Pharma Inc
- 6.4.1 RaQualia Pharma Inc Company Information
- 6.4.2 RaQualia Pharma Inc Business Overview
- 6.4.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
- 6.4.5 RaQualia Pharma Inc Recent Developments
- 6.5 Ono Pharmaceutical Co Ltd
- 6.5.1 Ono Pharmaceutical Co Ltd Company Information
- 6.5.2 Ono Pharmaceutical Co Ltd Business Overview
- 6.5.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
- 6.5.5 Ono Pharmaceutical Co Ltd Recent Developments
- 6.6 Kaken Pharmaceutical Co Ltd
- 6.6.1 Kaken Pharmaceutical Co Ltd Company Information
- 6.6.2 Kaken Pharmaceutical Co Ltd Business Overview
- 6.6.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
- 6.6.5 Kaken Pharmaceutical Co Ltd Recent Developments
7 North America
- 7.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026)
- 7.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026)
- 8.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026)
- 10.3 South America Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst